ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $238,740 | -25.7% | 8,885 | -1.4% | 0.01% | -27.3% |
Q2 2023 | $321,297 | +33.3% | 9,010 | -5.0% | 0.01% | +10.0% |
Q1 2023 | $240,995 | -37.4% | 9,488 | 0.0% | 0.01% | -47.4% |
Q4 2022 | $384,833 | -99.9% | 9,488 | +1.5% | 0.02% | +26.7% |
Q3 2022 | $309,018,000 | +108327.4% | 9,350 | +15.5% | 0.02% | +15.4% |
Q2 2022 | $285,000 | -24.4% | 8,093 | -1.3% | 0.01% | -7.1% |
Q1 2022 | $377,000 | -23.1% | 8,203 | +10.9% | 0.01% | -17.6% |
Q4 2021 | $490,000 | +21.9% | 7,395 | +14.8% | 0.02% | +13.3% |
Q3 2021 | $402,000 | -11.1% | 6,443 | +18.1% | 0.02% | -6.2% |
Q2 2021 | $452,000 | +44.9% | 5,456 | +16.0% | 0.02% | +23.1% |
Q1 2021 | $312,000 | – | 4,703 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |